Literature DB >> 21750513

Nonalcoholic fatty liver disease: Targeted therapy in children--what is the right way?

Anna Alisi, Valerio Nobili.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21750513     DOI： 10.1038/nrgastro.2011.117

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

Review 1.  Nonalcoholic fatty liver disease in children.

Authors:  Anna Alisi; Mattia Locatelli; Valerio Nobili
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

2.  Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial.

Authors:  Valerio Nobili; Giorgio Bedogni; Anna Alisi; Andrea Pietrobattista; Patrizia Risé; Claudio Galli; Carlo Agostoni
Journal:  Arch Dis Child       Date:  2011-01-12       Impact factor: 3.791

Review 3.  Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment.

Authors:  Anna Alisi; Stefano Cianfarani; Melania Manco; Carlo Agostoni; Valerio Nobili
Journal:  Ann Med       Date:  2011-02-28       Impact factor: 4.709

Review 4.  Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.

Authors:  Anna Iacono; Giuseppina Mattace Raso; Roberto Berni Canani; Antonio Calignano; Rosaria Meli
Journal:  J Nutr Biochem       Date:  2011-02-02       Impact factor: 6.048

Review 5.  Pathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-02       Impact factor: 46.802

6.  Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.

Authors:  Joel E Lavine; Jeffrey B Schwimmer; Mark L Van Natta; Jean P Molleston; Karen F Murray; Philip Rosenthal; Stephanie H Abrams; Ann O Scheimann; Arun J Sanyal; Naga Chalasani; James Tonascia; Aynur Ünalp; Jeanne M Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

7.  The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years.

Authors:  A E Feldstein; P Charatcharoenwitthaya; S Treeprasertsuk; J T Benson; F B Enders; P Angulo
Journal:  Gut       Date:  2009-07-21       Impact factor: 23.059

8.  Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.

Authors:  Joel E Lavine; Jeffrey B Schwimmer; Jean P Molleston; Ann O Scheimann; Karen F Murray; Stephanie H Abrams; Philip Rosenthal; Arun J Sanyal; Patricia R Robuck; Elizabeth M Brunt; Aynur Unalp; James Tonascia
Journal:  Contemp Clin Trials       Date:  2009-09-15       Impact factor: 2.226

9.  Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.

Authors:  Valerio Nobili; Melania Manco; Rita Devito; Vincenzo Di Ciommo; Donatella Comparcola; Maria Rita Sartorelli; Fiorella Piemonte; Matilde Marcellini; Paul Angulo
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

10.  Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

Authors:  Valerio Nobili; Melania Manco; Paolo Ciampalini; Anna Alisi; Rita Devito; Elisabetta Bugianesi; Matilde Marcellini; Giulio Marchesini
Journal:  Clin Ther       Date:  2008-06       Impact factor: 3.393
  10 in total
  5 in total

Review 1.  Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

Authors:  Anna Alisi; Ariel E Feldstein; Alberto Villani; Massimiliano Raponi; Valerio Nobili
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-17       Impact factor: 46.802

2.  Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats.

Authors:  Anna Alisi; Anna Pastore; Sara Ceccarelli; Nadia Panera; Daniela Gnani; Giovannella Bruscalupi; Mara Massimi; Giulia Tozzi; Fiorella Piemonte; Valerio Nobili
Journal:  Int J Mol Sci       Date:  2012-02-20       Impact factor: 6.208

3.  Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis.

Authors:  Anna Alisi; Sara Ceccarelli; Nadia Panera; Valerio Nobili
Journal:  Front Cell Infect Microbiol       Date:  2012-10-26       Impact factor: 5.293

Review 4.  Pediatric non-alcoholic fatty liver disease: an increasing public health issue.

Authors:  S Berardis; E Sokal
Journal:  Eur J Pediatr       Date:  2013-09-26       Impact factor: 3.183

Review 5.  Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD).

Authors:  Madhangi Parameswaran; Hamzah A Hasan; Jafor Sadeque; Sharan Jhaveri; Chaithanya Avanthika; Abimbola E Arisoyin; Maulik B Dhanani; Swaroopa M Rath
Journal:  Cureus       Date:  2021-12-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.